The #1 preferred glucose sensor by Canadian endocrinologists†,1 is now the most covered CGM on government funded programs in Ontario for people on insulin.*,2

Dexcom G7 is easy to use and prescribe
It’s covered by ODB and most private insurers for patients on insulin in Ontario. Write a prescription and your patient is set, no prior approval, LU codes, or forms are needed through ODB.
* For ODB eligible persons who are on insulin therapy for diabetes and who have a valid prescription for Dexcom G7 from a physician or nurse practitioner. Limit of 45 Dexcom G7 Sensors per eligible person per 365-day period. Dexcom G7 Receivers are also covered if there is no compatible smart device. For detailed coverage criteria, please visit dexcom.com/en-CA/coverage/ontario-provincial-cgm-coverage.
† Based on a survey of Canadian Endocrinologists (n=41)
‡ When compared with CGM systems commercially available in Canada as of October, 2023. Sensors worn on the back of the upper arm have been found to be slightly more accurate than sensors worn on the abdomen.
§ Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes. For more information, review the Dexcom G7 User Guide.
¶ The Dexcom G7 Sensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
# Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old.
** Smart devices sold separately. For a list of compatible devices, please visit dexcom.com/compatibility.
1 dQ&A, Dexcom Canadian Endos Report Wave 1 2024
2 Dexcom data on file, 2025
3 Beck, RW, et al. JAMA. 2017;317(4):371-378.
4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
5 Martens T, et al. JAMA. 2021;325(22):2262-2272.
6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
8 Aly A, et al. Diabetes Technol. Ther. 2024;26(S2): A254-255.
9 Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158.